Delivery Order SPE2DB20D3111-SPE2DB24FA8ZW
Award Date
9/5/24
Potential Completion Date
9/6/24
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) 80 mg/0.8 mL injectable medication. The contract has a firm fixed price of $3,694.32 and an ultimate completion date of August 1, 2024. This order is part of a larger Indefinite Delivery Contract between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Humira (adalimumab) Pen 40 mg/0.4 mL. The contract has a firm fixed price of $16,552.17 and a completion date of September 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a $19,434 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Humira (adalimumab) 40 mg/0.4 mL, a biologic medication used to treat various autoimmune conditions. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humira (adalimumab) 40 mg/0.4 mL pens, a medication used to treat various autoimmune conditions. The contract has a firm fixed price of $1,510.60 and a completion date of April 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Humira (adalimumab) 40 mg/0.4 mL, a biologic medication used to treat various autoimmune conditions. The contract has a ceiling value of $9,135.02 and an ultimate completion date of May 8, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply Humira (adalimumab) 40 mg/0.4 mL injections. The contract has a ceiling value of $15,420.62 and runs from March 5, 2024 through March 6, 2024. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,823.32, is for the delivery of Humira (adalimumab) 40 mg/0.4 mL, a biologic medication used to treat various autoimmune conditions. The contract is a firm-fixed-price delivery order with a period of performance through May 8, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) 40 mg/0.4 mL prefilled pens. The contract has a firm fixed price of $2,188.39 and a performance period through May 1, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,567.80, is for the supply of 4,568,093,520 units of the prescription medication HUMIRA 40 MG/0.8 ML SYRINGES. The contract has an ultimate completion date of May 1, 2025 and was awarded on April 30, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract, valued at $1,604.60, is for the delivery of HUMIRA 40 MG/0.8 ML SYRINGES to support military treatment programs and facilities. This contract is not set-aside. It is an individual delivery order placed under an indefinite delivery contract (IDC)...